Exelixis (EXEL) EVP Haley sells 32,110 shares, retains 357,638

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Exelixis, Inc. executive Patrick J. Haley reported an open‑market sale of 32,110 shares of Common Stock. The shares were sold at a weighted average price of $49.81 per share, with individual trades ranging from $49.80 to $49.89.

After this transaction, Haley directly holds 357,638 shares of Exelixis common stock. Footnote disclosure states that this figure includes 356,992 shares that will be issued upon vesting of restricted stock units and a performance-based restricted stock unit award, each convertible into one share of common stock.

Insider Trade Summary

Net Seller: 32,110 shares ($1,599,399)

Net Sell 1 txn

Insider Haley Patrick J.

Role EVP, Commercial

Sold 32,110 shs ($1.60M)

Type	Security	Shares	Price	Value
Sale	Common Stock	32,110	$49.81	$1.60M

Holdings After Transaction: Common Stock — 357,638 shares (Direct, null)

Footnotes (1)

Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.80 to $49.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Key Figures

Shares sold: 32,110 shares Weighted average sale price: $49.81 per share Sale price range: $49.80–$49.89 per share +2 more

5 metrics

Shares sold 32,110 shares Open-market sale on 2026-05-20

Weighted average sale price $49.81 per share Common Stock sale

Sale price range $49.80–$49.89 per share Multiple transactions within range

Shares held after transaction 357,638 shares Direct holdings following sale

RSUs and PSUs included 356,992 shares To be issued upon vesting of RSUs and performance-based units

Key Terms

weighted average sales price, restricted stock units ("RSUs"), performance-based restricted stock unit award, contingent right to receive one share

4 terms

weighted average sales price financial

"Represents the weighted average sales price. The shares of Exelixis, Inc. common stock were sold in multiple transactions..."

restricted stock units ("RSUs") financial

"Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs")..."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

performance-based restricted stock unit award financial

"...and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs")."

A performance-based restricted stock unit award is a promise to give company shares to an employee or executive only if the business hits specific targets over a set period. Think of it as a conditional prize that vests like a savings plan: if agreed goals (such as revenue, profit, or stock performance) are met, the recipient receives the shares; if not, they get nothing. Investors pay attention because these awards align management incentives with company results and can affect share count, future earnings and executive behavior.

Form 4 Insider Transactions: What Each Field Means →

05/22/2026 - 05:01 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Haley Patrick J.

(Last)

(First)

(Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA

CALIFORNIA

94502

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Commercial

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/20/2026		S		32,110	D	$49.81⁽¹⁾	357,638⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.80 to $49.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.

2. Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Exelixis (EXEL) report for Patrick J. Haley?

Exelixis reported that EVP, Commercial Patrick J. Haley sold 32,110 shares of Common Stock in an open‑market transaction. The sale used a weighted average price of $49.81 per share, with trades executed between $49.80 and $49.89.

At what price did Patrick J. Haley sell Exelixis (EXEL) shares?

Patrick J. Haley sold Exelixis shares at a weighted average price of $49.81 per share. The individual trades occurred in a narrow range, with prices between $49.80 and $49.89 according to the Form 4 footnote disclosure.

How many Exelixis (EXEL) shares does Patrick J. Haley hold after the sale?

After the reported sale, Patrick J. Haley holds 357,638 shares of Exelixis Common Stock. This amount includes 356,992 shares that will be issued upon vesting of restricted stock units and performance-based restricted stock unit awards, each representing one underlying share.

What types of equity awards are included in Patrick J. Haley’s Exelixis (EXEL) holdings?

Haley’s reported holdings include restricted stock units and a performance-based restricted stock unit award. The Form 4 states 356,992 shares of Common Stock will be issued upon vesting, with each RSU and performance-based unit economically equivalent to one share.

Was Patrick J. Haley’s Exelixis (EXEL) transaction a buy or a sell?

The transaction was a sale. The Form 4 identifies the transaction code as “S” for an open‑market sale, with 32,110 shares of Exelixis Common Stock sold at a weighted average price of $49.81 per share on the reported date.